List price: $85.00
Buy it from $27.08
This item qualifies for FREE shipping
*A minimum purchase of $35 is required. Shipping is provided via FedEx SmartPost® and FedEx Express Saver®. Average delivery time is 1 – 5 business days, but is not guaranteed in that timeframe. Also allow 1 - 2 days for processing. Free shipping is eligible only in the continental United States and excludes Hawaii, Alaska and Puerto Rico. FedEx service marks used by permission."Marketplace" orders are not eligible for free or discounted shipping.
30 day, 100% satisfaction guarantee
If an item you ordered from TextbookRush does not meet your expectations due to an error on our part, simply fill out a return request and then return it by mail within 30 days of ordering it for a full refund of item cost.
Learn more about our returns policy
Description: This work provides a thorough analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments.
Rush Rewards U
You have reached 400 XP and carrot coins. That is the daily max!
Limited time offer:
Get the first one free!
All the information you need in one place! Each Study Brief is a summary of one specific subject; facts, figures, and explanations to help you learn faster.
List price: $85.00
Copyright year: 2012
Publisher: Demos Medical Pub
Binding: Cloth Text
Size: 8.75" wide x 6.50" long x 0.50" tall
|Evolution of the Melanoma Staging System|
|Less Common Variants of Cutaneous Melanoma|
|Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma|
|Adjuvant Therapy for Melanoma|
|RAF Kinase Inhibitor Therapy in Melanoma|
|Emerging Targets for Melanoma Therapy Besides BRAF|
|Ipilimumab: The New Frontier of T-Cell Antibodies: A Paradigm Shift in Immuno-Oncology|
|Adoptive Cell Transfer Immunotherapy for Patients With Metastatic Melanoma|
|Immunotherapies for Metastatic Melanoma|
|Updated Approach to the Patient With Metastatic Melanoma|